Published in Cancer Weekly, May 25th, 1998
"Findings to be released at [the 1998] ASCO meeting are especially encouraging," said Robert J. Mayer, M.D., ASCO. "Information about the relative benefits of tamoxifen and raloxifene in preventing breast cancer [were] presented, as [well as] exciting new biologic therapies that may herald an entirely new era of cancer treatment."
More than 2,000...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.